{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:45:09Z","timestamp":1789854309100,"version":"4.0.1"},"reference-count":27,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1176\/appi.ajp.162.1.162","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T01:58:53Z","timestamp":1104371933000},"page":"162-167","source":"Crossref","is-referenced-by-count":92,"title":["Osteoporosis in Patients With Schizophrenia"],"prefix":"10.1176","volume":"162","author":[{"given":"Martina","family":"Hummer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf W.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy Cesar","family":"Moncayo Naveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rettenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1621CCHGJFFB","doi-asserted-by":"crossref","unstructured":"Halbreich U, Rojansky N, Palter S, Hreshchyshyn M, Kreeger J, Bakhai Y, Rosan R: Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995; 57:485\u2013491","DOI":"10.1097\/00006842-199509000-00011"},{"key":"R1621CCHGGJIF","doi-asserted-by":"crossref","unstructured":"Abraham G, Halbreich U, Friedman RH, Josiassen RC: Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr Res 2003; 59:17\u201318","DOI":"10.1016\/S0920-9964(01)00321-8"},{"key":"R1621CCHBDEGH","doi-asserted-by":"crossref","unstructured":"Parfitt AM: Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int 1979; 28:1\u20135","DOI":"10.1007\/BF02441211"},{"key":"R1621CCHBGIBE","doi-asserted-by":"crossref","unstructured":"Wolinsky-Friedland M: Drug-induced metabolic bone disease. Endocrinol Metab Clin North Am 1995; 24:395\u2013420","DOI":"10.1016\/S0889-8529(18)30046-X"},{"key":"R1621CCHDEIEG","doi-asserted-by":"crossref","unstructured":"Halbreich U, Kinon BJ, Gilmore JA, Kahn LS: Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 2003; 28:53\u201367","DOI":"10.1016\/S0306-4530(02)00112-9"},{"key":"R1621CCHGBCJI","doi-asserted-by":"crossref","unstructured":"Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW: Decreased bone density in hyperprolactinemic women. N Engl J Med 1980; 303:1511\u20131514","DOI":"10.1056\/NEJM198012253032605"},{"key":"R1621CCHIACAJ","doi-asserted-by":"crossref","unstructured":"Halbreich U, Palter S: Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull 1996; 22:447\u2013454","DOI":"10.1093\/schbul\/22.3.447"},{"key":"R1621CCHCEBHG","doi-asserted-by":"crossref","unstructured":"Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH: Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry 1993; 150:1408\u20131410","DOI":"10.1176\/ajp.150.9.1408"},{"key":"R1621CCHFFFHA","doi-asserted-by":"crossref","unstructured":"Cantor-Graae E, Nordstrom LG, McNeil TF: Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Bull 2001; 48:69\u201382","DOI":"10.1016\/S0920-9964(00)00114-6"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D: Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 2002; 62:743\u2013755","DOI":"10.2165\/00003495-200262050-00003"},{"key":"R1621CCHHHACI","doi-asserted-by":"crossref","unstructured":"DeLeon J, Verghese C, Tracy JI, Josiassen RC, Simpson GM: Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol Psychiatry 1994; 35:408\u2013419","DOI":"10.1016\/0006-3223(94)90008-6"},{"key":"R1621CCHFGAAC","doi-asserted-by":"crossref","unstructured":"Kay SR, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261\u2013276","DOI":"10.1093\/schbul\/13.2.261"},{"key":"R1621CCHJDBHI","doi-asserted-by":"crossref","unstructured":"White L, Harvey PD, Opler LA, Lindenmayer JP (PANSS Study Group): Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: a multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. Psychopathology 1997; 3:263\u2013274","DOI":"10.1159\/000285058"},{"key":"R1621CCHGBCEC","doi-asserted-by":"crossref","unstructured":"Schweiger U, Weber B, Deuschle M, Heuser I: Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am J Psychiatry 2000; 157:118\u2013120","DOI":"10.1176\/ajp.157.1.118"},{"key":"R1621CCHGABIH","unstructured":"Bergemann N, Auler B, Parzer P, Resch F, Mundt C, Ziegler R, Seibel M: High bone turnover but normal bone mineral density in women with schizophrenia (abstract). Bone 2001; 28:248"},{"key":"R1621CCHJFGBF","doi-asserted-by":"crossref","unstructured":"H\u00e4fner H, Maurer K, Loffler W, Fatkenheuer B, An der Heiden W, Riecher-R\u00f6ssler A, Behrens S, Gattaz WF: The epidemiology of early schizophrenia: influence of age and gender on onset and early course. Br J Psychiatry 1994; 23:29\u201338","DOI":"10.1192\/S0007125000292714"},{"key":"R1621CCHJCDEA","doi-asserted-by":"crossref","unstructured":"Becker D, Liver O, Mester R, Rapoport M, Weizman A, Weiss M: Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients. J Clin Psychiatry 2003; 64:761\u2013766","DOI":"10.4088\/JCP.v64n0704"},{"key":"R1621CCHCGFFJ","doi-asserted-by":"crossref","unstructured":"Kanis JA: Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359:1929\u20131936","DOI":"10.1016\/S0140-6736(02)08761-5"},{"key":"R1621CCHCDADI","doi-asserted-by":"crossref","unstructured":"Webb AR, Kline L, Holick MF: Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67:373\u2013378","DOI":"10.1210\/jcem-67-2-373"},{"key":"R1621CCHJHIBF","doi-asserted-by":"crossref","unstructured":"Sherman S: Preventing and treating osteoporosis: strategies at the millennium. Ann NY Acad Sci 2001; 949:188\u2013197","DOI":"10.1111\/j.1749-6632.2001.tb04020.x"},{"key":"R1621CCHDDDIA","doi-asserted-by":"crossref","unstructured":"Ovesen L: Vitamin therapy in the absence of obvious deficiency: what is the evidence? Drugs 1984; 27:148\u2013170","DOI":"10.2165\/00003495-198427020-00003"},{"key":"R1621CCHIBAGE","doi-asserted-by":"crossref","unstructured":"Rodrigues-Martinez MA, Garcia-Cohen EC: Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther 2002; 93:37\u201349","DOI":"10.1016\/S0163-7258(02)00164-X"},{"key":"R1621CCHDCJCC","doi-asserted-by":"crossref","unstructured":"Kanis JA (WHO Study Group): Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994; 4:368\u2013381","DOI":"10.1007\/BF01622200"},{"key":"atypb2","unstructured":"WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. World Health Organ Tech Rep Ser 1994; 843:1\u2013129"},{"key":"atypb3","unstructured":"Cooper C, Aihie A: Osteoporosis: recent advances in pathogenesis and treatment. Q J Med 1994; 87:203\u2013209"},{"key":"R1621CCHCEFFF","doi-asserted-by":"crossref","unstructured":"Kanis JA, Johnell O, Oden A, DeLae C, Jonsson B, Dawson A: Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002; 30:251\u2013258","DOI":"10.1016\/S8756-3282(01)00653-6"},{"key":"R1621CCHJEEFF","doi-asserted-by":"crossref","unstructured":"Garnero P, Sornay-Rendu E, Clustrat B, Delmas PD: Biochemical markers of bone turnover, endogenous hormone and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000; 15:1526\u20131536","DOI":"10.1359\/jbmr.2000.15.8.1526"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.1.162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T15:35:48Z","timestamp":1722180948000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.1.162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"alternative-id":["10.1176\/appi.ajp.162.1.162"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.162.1.162","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}